Morgan Stanley’s Impel Pharmaceuticals Inc. Common Stock IMPL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-2,000
| Closed | -$860 | – | 7950 |
|
|
2023
Q3 | $860 | Hold |
2,000
| – | – | ﹤0.01% | 7254 |
|
|
2023
Q2 | $2.54K | Hold |
2,000
| – | – | ﹤0.01% | 7140 |
|
|
2023
Q1 | $2.8K | Sell |
2,000
-142
| -7% | -$199 | ﹤0.01% | 7177 |
|
|
2022
Q4 | $8.03K | Sell |
2,142
-9,377
| -81% | -$35.2K | ﹤0.01% | 7012 |
|
|
2022
Q3 | $55K | Sell |
11,519
-4,147
| -26% | -$19.8K | ﹤0.01% | 6369 |
|
|
2022
Q2 | $145K | Buy |
15,666
+4,554
| +41% | +$42.2K | ﹤0.01% | 6066 |
|
|
2022
Q1 | $70K | Sell |
11,112
-967
| -8% | -$6.09K | ﹤0.01% | 6530 |
|
|
2021
Q4 | $105K | Buy |
12,079
+5,730
| +90% | +$49.8K | ﹤0.01% | 6413 |
|
|
2021
Q3 | $78K | Sell |
6,349
-1,539
| -20% | -$18.9K | ﹤0.01% | 6505 |
|
|
2021
Q2 | $69K | Buy |
+7,888
| New | +$69K | ﹤0.01% | 6523 |
|